0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Infantile hepatic hemangioma misdiagnosed by prenatal ultrasonography : A case report

      case-report

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Rationale:

          The drastic differences in treatment and prognosis of infantile hepatic hemangioma (IHH) and hepatoblastoma (HBL) make accurate prenatal diagnosis imperative. The retrospective comparisons of ultrasonic features between fetal IHH and HBL have been reported before, but clinically, the differential diagnosis in utero is very difficult and can lead to prenatal misdiagnosis.

          Patient concerns:

          A 27-year-old woman at 30 gestational weeks underwent the routine prenatal examination. A heterogeneous solid mass of the fetus, with close relationship to the liver, was recognized by ultrasound.

          Diagnosis:

          A diagnosis of HBL was highly considered.

          Interventions:

          The fetus was aborted and the autopsy was performed.

          Outcomes:

          The histological outcome was IHH.

          Lessons:

          The prognosis of fetal IHH and HBL is very different, so an accurate diagnosis prenatally is crucial and indispensable. The radiologist and clinician should differentiate between IHH and HBL, especially since the fetus can have serious complications.

          Related collections

          Most cited references21

          • Record: found
          • Abstract: found
          • Article: not found

          Hepatoblastoma: recent developments in research and treatment.

          Hepatoblastoma is the most common liver tumor of early childhood. According to recent studies its incidence seems to be increasing in North America and Europe. Since new histological variants have been described recently the formerly clear-cut distinction of hepatoblastoma and hepatocellular carcinoma may not be valid anymore and a new histological classification will be inaugurated by an international working group. Recent research identified prognostically relevant gene signatures as well as potential molecular targets for therapy of hepatoblastoma. The multicentric study groups in the USA, Europe and Japan recommend cisplatin based chemotherapy for neoadjuvant and adjuvant treatment. However, their risk stratification systems and general treatment strategies differ substantially. Therefore the four groups agreed to pool their patients' data for an analysis of prognostic criteria which can be used for defining common risk groups. While 90% of standard risk and 65% of high risk hepatoblastomas can be cured, the still dismal outcome of multifocal disseminated and metastasising tumors warrants the investigation of new cytotoxic drugs and substances against specific molecular targets. Copyright © 2012 Elsevier Inc. All rights reserved.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Hepatic vascular tumors.

            The most common hepatic vascular tumor in the pediatric population is the infantile hepatic hemangioma. Although these lesions have a spectrum of presentations, there are three main subtypes that have been described-focal, multifocal, and diffuse. An algorithm on the workup, treatment, and follow-up of these lesions can be based on this categorization. Recent shifts in the management of hemangiomas with beta-blockers (propranolol) have also influenced the treatment of hepatic hemangiomas. This article reviews the current understanding of hepatic hemangiomas and protocols in the management of these patients.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Fetal and neonatal liver tumours.

              Liver tumours are rare in children and account for about 5% of all tumours in the fetus and newborn. The most frequently occurring are benign vascular tumours and mesenchymal hamartomas although malignancy in the form of hepatoblastoma is a possibility. While the diagnosis can be suspected antenatally (by ultrasound and MR scan), a precise diagnosis is often difficult due to the complexity of the tumours. Inutero development of such tumours may be associated with polyhydramnios, fetal hydrops and extreme cases the maternal mirror syndrome. Postnatal symptoms may include abdominal distension, cardiac failure, consumptive coagulopathy and bleeding due to tumour rupture, but is dependent on the nature of the actual tumour. Treatment options may include watchful waiting, surgical resection, hepatic artery embolisation/ligation and chemotherapy.
                Bookmark

                Author and article information

                Journal
                Medicine (Baltimore)
                Medicine (Baltimore)
                MEDI
                Medicine
                Lippincott Williams & Wilkins (Hagerstown, MD )
                0025-7974
                1536-5964
                15 January 2021
                15 January 2021
                : 100
                : 2
                : e24242
                Affiliations
                [a ]Department of Ultrasound
                [b ]Key Laboratory of Obstetrics and Gynecology and Pediatric Diseases and Birth Defects of Ministry of Education, West China Second Hospital of Sichuan University
                [c ]Department of Pathology, West China Hospital of Sichuan University
                [d ]Chengdu Chenghua District Maternal and Child Health Hospital, Chengdu, Sichuan, China.
                Author notes
                []Correspondence: Fan Yang, Department of Ultrasound, West China Second Hospital of Sichuan University, Renmin South Road, Section 3, Number 20, Chengdu, Sichuan, 610041, China/Chengdu Chenghua District Maternal and Child Health Hospital, Chengdu, Sichuan, China (e-mail: jessica1975cd@ 123456163.com ).
                Article
                MD-D-20-00384 24242
                10.1097/MD.0000000000024242
                7808497
                33466207
                e5bbc82e-b9a5-4042-a2d3-03892848382a
                Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.

                This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0

                History
                : 28 January 2020
                : 6 December 2020
                : 17 December 2020
                Funding
                Funded by: The New sprout fund of West China Second University Hospital
                Award ID: kx067
                Award Recipient : Ya Jin
                Funded by: National Key Research and Development Plan
                Award ID: 2017YFC0113905
                Award Recipient : Hong Luo
                Funded by: International Cooperation Project of Sichuan Science and Technology Department
                Award ID: 20GJHZ0198
                Award Recipient : Fan Yang
                Categories
                5600
                Research Article
                Clinical Case Report
                Custom metadata
                TRUE

                differential diagnosis,fetus,hepatoblastoma,infantile hepatic hemangioma,ultrasound

                Comments

                Comment on this article